Jesus Ernesto Echevarria Barron

Sr. Project Engineer at ThermoGenesis

Jesus Ernesto Echevarria Barron has a solid work experience in the engineering industry. Jesus Ernesto started their career as an Ingeniero de diseño mecánico at KOSTAL Group in 2015, where they worked until 2016. Following that, they joined Nypro, a Jabil Company, in 2016 as an Ingeniero de Manufactura and continued working there until 2020. In 2020, Jesus transitioned to Cardinal Health, where they served as an Ingeniero de Manufactura Sr. NPI until 2022. Currently, they are working as a Sr. Project Engineer at ThermoGenesis Holdings, Inc.

Jesus Ernesto Echevarria Barron's education history is as follows:

In 2010 to 2015, Jesus Ernesto Echevarria Barron attended the Instituto Tecnologico de Culiacan, where they pursued a Bachelor's degree in Engineering with a focus on electronic, robotic, and mechatronic engineering.

In 2019, Jesus Ernesto Echevarria Barron attended the Academia de Lean, where they obtained a Green Belt in Lean Six Sigma. Additionally, they completed a program on process validation for the medical industry at the same institution.

In the same year, Jesus Ernesto Echevarria Barron also studied Program Management at CETYS Universidad.

In 2020, they pursued a degree in Manufacturing Engineering and specialized in medical devices validation at CETYS Universidad.

In 2021, Jesus Ernesto Echevarria Barron attended CETYS Universidad again, where they completed a program in Lean and became a Six Sigma Black Belt.

Looking ahead, in 2022 and beyond, they are expected to pursue a degree in Cost Engineering at CETYS Universidad with a focus on finance, specifically in the field of general finance.

Location

Tijuana, Mexico

Links

Previous companies


Org chart

No direct reports

Teams


Offices

This person is not in any offices


ThermoGenesis

1 followers

ThermoGenesis Holdings, Inc. is an industry leader in the development and commercialization of automated cell processing technologies for the cell and gene therapy fields. They offer a full suite of solutions for automated clinical biobanking, point-of-care applications, and large scale cellular processing and manufacturing for the emerging CAR-T immunotherapy market.


Industries

Employees

11-50

Links